-
1
Prevalence of non-alcoholic fatty liver disease at obesity and its interrelation with cardio-vascular disease and 2nd type diabetes mellitus risk factors
Published 2012-04-01Subjects: “…risk factors of cardio-vascular diseases…”
Get full text
Article -
2
Efficacy of parenteral pantoprazole in patients with acute ulcerative gastroduodenal bleeding at high risk of relapse
Published 2012-04-01“…In 17 cases ulcerative bleeding developed on a background of severe concomitant cardio-vascular disease. Of them 19 were men, 11 – women, mean age 53 and 73 years respectively, 81,8 % of patients over 65 years old. …”
Get full text
Article -
3
Probiotics, metabolism and the functional condition of cardio-vascular system
Published 2016-08-01“…Microbiome may be involved in development of cardio-vascular diseases and atherosclerosis due to metabolic symbiosis with the host. …”
Get full text
Article -
4
Epidemiologic features of non-alcoholic fatty liver disease in Russia
Published 2014-10-01“…The impact of all studied risk factors of cardio-vascular diseases (р<0,001) has been found. The major risk factors revealed in NAFLD patients population, were systemic hypertension (69,9%), abdominal obesity (56,2%), hypercholesterolemia (68,8%).Conclusions. …”
Get full text
Article -
5
Food as a lifestyle
Published 2018-08-01“…Presented principles will help healthy people to maintain active longevity by prevention of cardio-vascular diseases, Alzheimer's disease and some other disorders. …”
Get full text
Article -
6
Pantoprazole – safety in drug-drug interaction
Published 2012-09-01“…This is proved by relative safety of clopidogrel to pantoprazole combination in patients with cardio-vascular diseases, demonstrated in clinical studies of the last years.Conclusion. …”
Get full text
Article -
7
Chronic hepatitis C course at elderly and therapeutic approach
Published 2011-02-01“…One of the basic problems during antiviral therapy is development of ribavirin-induced anemia that is especially dangerous at patients with cardio-vascular diseases. This complication requires careful monitoring of hemoglobin and hematocrit level during the whole period of treatment and, if necessary, decline of drug doses according to established algorithms.Conclusion. …”
Get full text
Article -
8
The role of gut microbiota in disease management: Ayurvedic perspectives on metabolic diseases and health
Published 2025-02-01“…These have direct or indirect effects on an individual's health and diseases, viz. dysbiosis, UC, IBD, cardio-vascular diseases, chronic kidney disorders, etc. The interaction of various phytoconstituents present in the MFH plants with the gut microbiota has a two-way effect. …”
Get full text
Article